Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Journal of Biological Response Modifiers|January 1, 1983
Clinical immunotherapy trials of bacterial components derived from Mycobacteria and NocardiaG J VosikaCancer Treatment Reports|September 1, 1983
Phase I study of iv mycobacterial cell wall skeleton and cell wall skeleton combined with trehalose dimycolateG J Vosika, G R GrayVaccine|November 19, 1997
The muramyl dipeptide analog GMTP-N-DPG preferentially induces cellular immunity to soluble antigensD J Fast, G J VosikaCancer Immunology, Immunotherapy : CII|January 1, 1984
Phase-I study of intravenous modified lipid AG J Vosika, C Barr, D GilbertsonCancer|May 1, 1978
CCNU-adriamycin therapy in bronchogenic carcinomaR C Trowbridge, B J Kennedy, G J VosikaBiochimica Et Biophysica Acta|March 28, 1979
Analysis of the genetic complexity and abundance classes of messenger RNA in human liver and leukemic cellsR S Ostrow, W G Woods, G J Vosika, et al.American Journal of Clinical Oncology|October 1, 1983
Vindesine for metastatic malignant melanoma. A phase II trialR A Nelimark, B A Peterson, G J Vosika, et al.Cancer|March 15, 1980
Comparison of tamoxifen and hypophysectomy in breast cancer treatmentD T Kiang, D H Frenning, G J Vosika, et al.American Journal of Clinical Oncology|February 1, 1982
Vindesine in bronchogenic carcinoma: a phase II trialN J Vogelzang, B A Peterson, B J Kennedy, et al.Cancer|August 1, 1979
Intralesional immunotherapy of malignant melanoma with mycobacterium smegmatis cell wall skeleton combined with trehalose dimycolate (P3)G J Vosika, J R Schmidtke, A Goldman, et al.Pageof 2